Get inspired and join us for the 2010 World Stem Cell Summit October 4-6, at the Renaissance Center Detroit, Michigan.

2010 CONFERENCE OVERVIEW
2010 marks the 3rd annual World Stem Cell Summit and the 6th annual event produced by the Genetics Policy Institute, a 501c3 non-profit advocacy organization dedicated to uniting, educating and empowering the global stem cell and regenerative medicine community.

Past event partners include:
2009 World Stem Cell Summit: Johns Hopkins University, Maryland Department of Business and Economic Development, Maryland Stem Cell Research Fund, Maryland Technology Development Corporation, University System of Maryland University
2008 World Stem Cell Summit: University of Wisconsin-Madison Stem Cell and Regenerative Medicine Center and WiCell Research Institute
2007 Stem Cell Summit: Harvard Stem Cell Institute and Burrill Life Science Media Group
2006 Stem Cell Policy Summit: Stanford University and Baylor College of Medicine
2005 Stem Cell Advocacy Summit: Baylor College of Medicine

Unparalleled Agenda
The World Stem Cell Summit program agenda is strategically designed to unite the international stem cell community and highlight the field’s most brilliant minds and crucial pioneers to provide an orbital state-of-the-art view of the expanding stem cell universe.

This year’s diverse 3-day agenda will include morning keynotes and plenary discussions, roundtable lunch conversations with experts, a focused science, industry and society track as well as intimate workshops intended to meet the needs of all World Stem Cell Summit attendees. 

2010 World Stem Cell Summit Program Overview:
Science:  Compelling science presentations highlighting 2010's research breakthroughs, progressive research strategies and cross disciplinary initiatives.  Topics cover Human Embryonic Stem Cells; Induced Pluripotent Stem Cells; Neural Stem Cell; Cardiac; Cancer Stem Cell; Mesenchymal and Hematopoietic Stem Cells; Nanotechnology and Bioengineering; Stem Cells and Disease Modeling; Cellular Differentiation and Dedifferentiation and Research Funding Opportunities

Business & Law: Key Technologies of the ReGEN Industry; The Role of Big Pharma, Big Biotech, Big Device; Key Transformation Medical Technologies and Services, Clinical Proof of Concept, Regulatory and Reimbursement Strategies; Commercialization, Drug Discovery, International Alliances, Insurance Questions, The Cord Blood Industry & Cell Banking, Partnerships and Acquisitions, Advanced Intellectual Property Issues, Venture Capital Insight, International Market Trends, Licensing, Technology Transfer,  Successful Business Models Innovative Funding Mechanisms and more.

Medicine:  Disease focus sessions and workshops designed for physicians, healthcare providers and consumers. Sessions will cover translational and preclinical findings in Spinal Cord Injury and Multiple Sclerosis; Cancer; Cardiovascular; Diabetes; Blindness, Aging and Rare Diseases; Parkinson’s / ALS / Neurological Disorders.  

International Discussions: International Strategies, Partnerships and Collaborations; Stem Cells and the Potential for National and Regional Economic Development; Stem Cells in Clinical Treatments and Medical Tourism; International Standards and Regulations; Regenerative Medicine for Wounded Soldiers; Case Study on Michigan’s Investment in Stem Cell Science; Cord Blood and Cell Banking and more.

Ethics and Advocacy:  Stem Cell Action—A New Agenda for Advocates, Philanthropic Opportunities, Ethics and Societal Issues, Understanding Federal Policy, Drug Development Timelines and Medical Tourism Concerns and Guidelines.

Conference Organizers and Introduction:
Presented by the Genetics Policy Institute, the 2010 Summit is hosted by University of Michigan, Michigan State University, Wayne State University, University research Corridor and the Michigan Economic Development Corporation. The World Stem Cell Summit is the flagship event, bringing together the founding visionary researchers, clinicians, business pathfinders, key policy-makers, regulators, advocates, experts in law and ethics to present compelling presentations, share information, and together chart the future of regenerative medicine.

Conference Co-Chairs:
Steve Forrest, vice-president of research, University of Michigan; Ian Gray, vice-president of research, Michigan State University; Hilary Ratner, vice-president of research, Wayne State University and Bernard Siegel, executive director, Genetics Policy Institute.

Conference History:
The 2010 World Stem Cell Summit marks the sixth annual summit presented by the Genetics Policy Institute. Past event partners include: Johns Hopkins University, University System of Maryland, the State of Maryland, University of Wisconsin-Madison Stem Cell & Regenerative Medicine Center, WiCell Research Institute, Harvard Stem Cell Institute, Stanford University, Baylor College of Medicine and the United Nations. The 2009 summit attracted attendees from 35 states and 27 countries.

Conference Topics:
2010 panel discussions will focus on the science, business, policy, law and ethics of all stem cell types including human embryonic stem cells, adult stem cells and induced pluripotent stem cells.

To maximize the potential of stem cell research, the 2010 World Stem Cell Summit program is designed to cover the field’s most pressing topics including: progressive research strategies, translational and preclinical findings, cross disciplinary initiatives, drug discovery, funding opportunities (federal, public and private), commercialization plans, technology transfer platforms, venture capital insight, market trends, regulatory issues, ethical and societal implications, philanthropic opportunities, medical tourism challenges, cell banking projects, intellectual property landscapes, insurance questions, international perspectives, clinical use and the pressing advocacy agenda.
of the world's most prominent scientists addressing the latest discoveries

Conference Attendees:
We anticipate the 2010 World Stem Cell Summit to attract more than 1,400 of the world’s most influential stem cell stakeholders in science, business, policy, law, ethics and advocacy. Additionally, 125 plus internationally renowned speakers will be present—producing a unique international network designed to foster collaborations, economic development, technology transfer, commercialization, private investment and philanthropy.

Conference Exhibitors:
Sixty world leading stem cell companies, organizations, states and nations will showcase cutting edge products, research breakthroughs, investment strategies and government initiatives to advance this burgeoning field.

Don't miss this opportunity. Space is limited, so register now!  Sponsor and exhibit opportunities are now available. Contact Alan Fernandez to learn more.